Alaska Air Group, Inc (ALK) Stock Price

42.93 ▲ +1.80 (+4.38%)
Open: 40.74 Vol: 3.11M Day's range: 40.24 - 43.448 Nov 07, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALK Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 42.93▲ 42.55▲ 42.38▲ 41.48▲ 44.59▼
MA10 42.93▲ 42.21▲ 41.96▲ 41.94▲ 50.68▼
MA20 42.81▲ 41.81▲ 41.76▲ 44.83▼ 52.42▼
MA50 42.28▲ 41.41▲ 41.37▲ 51.40▼ 55.64▼
MA100 41.89▲ 41.44▲ 43.53▼ 52.33▼ 48.17▼
MA200 41.71▲ 43.87▼ 46.05▼ 54.32▼ 46.90▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.027▼ 0.134▲ 0.180▲ 0.082▲ -1.631▼
RSI 62.371▲ 70.664▲ 65.792▲ 40.109▼ 36.226▼
STOCH 50.172     80.286▲ 86.050▲ 26.495     4.844▼
WILL %R -41.463     -15.287▲ -15.287▲ -66.810     -88.066▼
CCI 23.217     157.578▲ 163.300▲ -34.841     -120.972▼
Latest Filters Detected On ALK
▲ MACD $ALK MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $ALK Price Crossed Above MA(13) Set Alert
MA $ALK Price Crossed Above MA(7) Set Alert
CDL $ALK Engulfing Candlestick Pattern Detected Set Alert
Alaska Air Group, Inc News
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow ...
Friday, November 07, 2025 05:18 AM
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of Livdelzi® (seladelpar) for people living with primary biliary cholangitis (PBC).
Invitation to the presentation of ALK’s first nine months (Q3) 2025 results on Thursday, 13 November 2025
Thursday, November 06, 2025 08:15 AM
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first nine months (Q3) of 2025 in the morning on Thursday, 13 November 2025. Later on the same day, the company will host a presentation for ...
Nuvalent: Interesting Product, But Aggressive Valuation
Tuesday, November 04, 2025 05:28 PM
Nuvalent is approaching the precipice of a first targeted therapy approval in lung cancer. Click here to read why NUVL stock is a Sell.
ALK historical stock data
date open high low close volume
07/11/25 40.74 43.448 40.24 42.93 3,110,528
06/11/25 41.70 42.35 40.59 41.13 2,378,038
05/11/25 40.48 42.45 40.3275 41.86 6,222,914
04/11/25 40.44 41.06 39.8201 40.42 2,762,129
03/11/25 41.80 41.95 40.80 41.07 3,043,525
31/10/25 40.50 41.80 40.455 41.73 3,001,190
30/10/25 41.25 41.805 40.65 40.70 2,757,716
29/10/25 42.82 43.25 41.33 41.77 5,169,591
28/10/25 44.36 44.50 42.97 43.00 3,930,890
27/10/25 44.53 45.03 43.97 44.78 4,309,167
Quote Details
52wk Low:39.79
52wk High:78.08
Vol:3.11M
Avg Vol(3m):52.2M
1Y Chng:-18.10%
1M Chng:-14.89%
Add to Watch List
More Information
Index N/A
Market Cap. 4.74B